Search

Search Constraints

You searched for: Author/Creator Robson, Mark

Search Results

4. Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. (December 2017)

5. Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial. (October 2019)

8. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (12th October 2018)

9. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status. Issue 5 (1st March 2020)